944 related articles for article (PubMed ID: 17161420)
1. A comparative study of different vector designs for the mammalian expression of recombinant IgG antibodies.
Li J; Menzel C; Meier D; Zhang C; Dübel S; Jostock T
J Immunol Methods; 2007 Jan; 318(1-2):113-24. PubMed ID: 17161420
[TBL] [Abstract][Full Text] [Related]
2. On the optimal ratio of heavy to light chain genes for efficient recombinant antibody production by CHO cells.
Schlatter S; Stansfield SH; Dinnis DM; Racher AJ; Birch JR; James DC
Biotechnol Prog; 2005; 21(1):122-33. PubMed ID: 15903249
[TBL] [Abstract][Full Text] [Related]
3. Auditioning of CHO host cell lines using the artificial chromosome expression (ACE) technology.
Kennard ML; Goosney DL; Monteith D; Roe S; Fischer D; Mott J
Biotechnol Bioeng; 2009 Oct; 104(3):526-39. PubMed ID: 19544304
[TBL] [Abstract][Full Text] [Related]
4. Analysis of IgG heavy chain to light chain ratio with mutant Encephalomyocarditis virus internal ribosome entry site.
Li J; Zhang C; Jostock T; Dübel S
Protein Eng Des Sel; 2007 Oct; 20(10):491-6. PubMed ID: 17951613
[TBL] [Abstract][Full Text] [Related]
5. Efficient expression of recombinant human monoclonal antibodies in Drosophila S2 cells.
Johansson DX; Drakenberg K; Hopmann KH; Schmidt A; Yari F; Hinkula J; Persson MA
J Immunol Methods; 2007 Jan; 318(1-2):37-46. PubMed ID: 17137589
[TBL] [Abstract][Full Text] [Related]
6. Production of functional antibodies generated in a nonlytic insect cell expression system.
Li E; Brown SL; Dolman CS; Brown GB; Nemerow GR
Protein Expr Purif; 2001 Feb; 21(1):121-8. PubMed ID: 11162396
[TBL] [Abstract][Full Text] [Related]
7. Control of IgG LC:HC ratio in stably transfected CHO cells and study of the impact on expression, aggregation, glycosylation and conformational stability.
Ho SC; Koh EY; van Beers M; Mueller M; Wan C; Teo G; Song Z; Tong YW; Bardor M; Yang Y
J Biotechnol; 2013 Jun; 165(3-4):157-66. PubMed ID: 23583871
[TBL] [Abstract][Full Text] [Related]
8. The generation of stable, high MAb expressing CHO cell lines based on the artificial chromosome expression (ACE) technology.
Kennard ML; Goosney DL; Monteith D; Zhang L; Moffat M; Fischer D; Mott J
Biotechnol Bioeng; 2009 Oct; 104(3):540-53. PubMed ID: 19557833
[TBL] [Abstract][Full Text] [Related]
9. Impact of gene vector design on the control of recombinant monoclonal antibody production by Chinese hamster ovary cells.
Davies SL; O'Callaghan PM; McLeod J; Pybus LP; Sung YH; Rance J; Wilkinson SJ; Racher AJ; Young RJ; James DC
Biotechnol Prog; 2011; 27(6):1689-99. PubMed ID: 21882365
[TBL] [Abstract][Full Text] [Related]
10. High-level expression of proteins in mammalian cells using transcription regulatory sequences from the Chinese hamster EF-1alpha gene.
Running Deer J; Allison DS
Biotechnol Prog; 2004; 20(3):880-9. PubMed ID: 15176895
[TBL] [Abstract][Full Text] [Related]
11. Recombinant polymeric IgG anti-Rh: a novel strategy for development of direct agglutinating reagents.
Montano RF; Penichet ML; Blackall DP; Morrison SL; Chintalacharuvu KR
J Immunol Methods; 2009 Jan; 340(1):1-10. PubMed ID: 18848836
[TBL] [Abstract][Full Text] [Related]
12. Control of culture environment for improved polyethylenimine-mediated transient production of recombinant monoclonal antibodies by CHO cells.
Galbraith DJ; Tait AS; Racher AJ; Birch JR; James DC
Biotechnol Prog; 2006; 22(3):753-62. PubMed ID: 16739959
[TBL] [Abstract][Full Text] [Related]
13. An Efficient Transient Expression System for Enhancing the Generation of Monoclonal Antibodies in 293 Suspension Cells.
Zhang G; Liu J; Fan W; Chen Q; Shi B
Curr Pharm Biotechnol; 2017; 18(4):351-357. PubMed ID: 28322160
[TBL] [Abstract][Full Text] [Related]
14. Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells.
Chng J; Wang T; Nian R; Lau A; Hoi KM; Ho SC; Gagnon P; Bi X; Yang Y
MAbs; 2015; 7(2):403-12. PubMed ID: 25621616
[TBL] [Abstract][Full Text] [Related]
15. [Construction of expression vector for human-mouse chimeric antibody and expression of an antibody against human HER2].
Wang LL; Han H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):363-5. PubMed ID: 15193240
[TBL] [Abstract][Full Text] [Related]
16. IRES-mediated Tricistronic vectors for enhancing generation of high monoclonal antibody expressing CHO cell lines.
Ho SC; Bardor M; Feng H; Mariati ; Tong YW; Song Z; Yap MG; Yang Y
J Biotechnol; 2012 Jan; 157(1):130-9. PubMed ID: 22024589
[TBL] [Abstract][Full Text] [Related]
17. High levels of protein expression using different mammalian CMV promoters in several cell lines.
Xia W; Bringmann P; McClary J; Jones PP; Manzana W; Zhu Y; Wang S; Liu Y; Harvey S; Madlansacay MR; McLean K; Rosser MP; MacRobbie J; Olsen CL; Cobb RR
Protein Expr Purif; 2006 Jan; 45(1):115-24. PubMed ID: 16289982
[TBL] [Abstract][Full Text] [Related]
18. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.
Alvarez-Rueda N; Leprieur S; Clémenceau B; Supiot S; Sébille-Rivain V; Faivre-Chauvet A; Davodeau F; Paris F; Barbet J; Aubry J; Birklé S
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797
[TBL] [Abstract][Full Text] [Related]
19. Cell line-specific control of recombinant monoclonal antibody production by CHO cells.
O'Callaghan PM; McLeod J; Pybus LP; Lovelady CS; Wilkinson SJ; Racher AJ; Porter A; James DC
Biotechnol Bioeng; 2010 Aug; 106(6):938-51. PubMed ID: 20589672
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the EF-1 alpha and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus.
Teschendorf C; Warrington KH; Siemann DW; Muzyczka N
Anticancer Res; 2002; 22(6A):3325-30. PubMed ID: 12530082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
